CoChat

Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates

Wagner, Anita K., Ross-Degnan, Dennis, Gurwitz, Jerry H., Zhang, Fang, Gilden, Daniel B., Cosler, Leon, Soumerai, Stephen B. · 2007 · Annals of Internal Medicine
Cited by 73

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Medicare Part D excludes benzodiazepines from coverage, and numerous state government policies limit use of benzodiazepines. No data indicate that such policies have decreased the incidence of hip fracture. OBJECTIVE: To assess whether a statewide policy that decreased the use of benzodiazepines among elderly persons by more than 50% has decreased the incidence of hip fracture. DESIGN: A quasi-experiment comparing changes in outcomes before and after a policy change in a study U.S. state (New York) and a control state (New Jersey). SETTING: Two U.S. state Medicaid programs, 1988-1990. PATIENTS: Medicaid enrollees in New York (n = 51 529) and New Jersey (n = 42 029) who received or did not receive a benzodiazepine. MEASUREMENTS: Benzodiazepine prescribing and hazard ratios for hip fracture, adjusted for age and eligibility category. INTERVENTION: A statewide policy, implemented in New York in 1989, that required triplicate forms for benzodiazepine prescribing to allow surveillance by health authorities. RESULTS: The triplicate prescription policy immediately resulted in a 60.3% (95% CI, -66.3% to -54.2%) reduction in benzodiazepine use among women and 58.5% (-64.3% to -52.8%) among men. Benzodiazepine use in New Jersey remained stable. Hazard ratios for hip fracture that were adjusted for age and eligibility category did not change in New York or New Jersey when the periods before and after use of the triplicate prescription policy were compared (change from 1.2 to 1.1 among female benzodiazepine recipients [P = 0.70], 1.3 to 1.1 [P = 0.08] among female nonrecipients, 0.8 to 1.1 [P = 0.56] among male recipients, and 1.1 to 1.3 [P = 0.46] among male nonrecipients). LIMITATIONS: Information was lacking on race, benzodiazepine dose, and other potential determinants of continued benzodiazepine prescribing. CONCLUSIONS: Policies that lead to substantial reductions in the use of benzodiazepines among elderly persons do not necessarily lead to decreased incidence of hip fracture. Limitations on coverage of benzodiazepines under Medicare Part D may not achieve this widely assumed clinical benefit.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-146-2-200701160-00004

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 73

Metadata

Authors
Wagner, A. K., Ross-Degnan, D., Gurwitz, J. H., Zhang, F., Gilden, D. B., Cosler, L., & Soumerai, S. B.
Venue
Annals of Internal Medicine
Published
2007-01-16
Volume
146
Issue
2
Pages
96-103
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2017489491
Cited by
73
References
2
FWCI
3.32
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates. https://app.cochat.ai/papers/10.7326/0003-4819-146-2-200701160-00004
The paper
Wagner, A. K., Ross-Degnan, D., Gurwitz, J. H., Zhang, F., Gilden, D. B., Cosler, L., & Soumerai, S. B. (2007). Effect of New York State Regulatory Action on Benzodiazepine Prescribing and Hip Fracture Rates. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-146-2-200701160-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.